Hutch News
Results per Page:
Lessons from cancer patients in the time of coronavirus
For the immunocompromised and those with disease, social distancing and uncertainty are a way of life. Daily walks, gratitude and dancing help.
Big gains in bone marrow transplant survival since mid-2000s
Despite older, sicker patients, mortality rate dropped by one-third within 10-year period
Does CAR T-cell therapy leave patients vulnerable to infection?
$3.3M Cancer Moonshot grant to study how immunotherapy impacts patients’ ability to fight off bugs
Try, try again: Can a 2nd dose of CAR T cells succeed when the first fails?
First-of-its-kind study offers early indication of factors linked to increased odds of success for patients out of options
Dr. Cameron Turtle receives Anderson Family Endowed Chair for Immunotherapy
Gift will ‘help new ideas move rapidly toward the patients who need them’
Remembering transplant immunologist Dr. John Hansen
Physician-scientist defined rules for matching bone marrow transplant donors and patients, was a founding father of volunteer donor registries
Leukemia research leader Dr. Fred Appelbaum named ‘Giant of Cancer Care’
Physician-scientist and Hutch VP honored for contributions to research, patient care
Study aims to cure blood cancers with transplants that could block HIV, too
10 HIV-positive cancer patients to receive donated cord blood with rare resistance gene
Hutch science featured at world's premier cancer immunotherapy meeting
Researchers honored at SITC 2018 for work on immune-based treatments for leukemia, ovarian cancer, skin cancer
Taking the shortcut to frontline treatment
From Dr. Schmitt and the Radich lab, Clinical Research Division
Lyani Valle: leukemia survivor, Obliteride walker
'Cancer was a huge wake-up call to what is important in life'
3 big new leukemia research projects advance cutting-edge cell therapies, stem cell transplant
$20M renewal of 4-decade-long federal grant to Hutch scientists
Seattle Times' Pacific NW Magazine profiles Fred Hutch
Seattle Times’ Sunday feature looks at the melding of expertise, drive and technology making new cures possible
Health disparities may affect end-of-life experiences of minority blood cancer patients
A new study finds ethnic and racial minorities with leukemia or lymphoma are more likely to die in hospital, receive aggressive care in last weeks of life than white patients
KUOW profiles E. Donnall Thomas and his Nobel Prize-winning work on a once 'radical' cure for leukemia
Fred Hutch research in bone marrow transplantation helped establish Seattle's biotech industry
Dr. Cecilia Yeung awarded Hyundai Scholar Hope Grant for childhood leukemia research
Yeung developing test to diagnose acute leukemia earlier, provide personalized treatment
Fred Hutch scientist awarded Hyundai Scholar Hope Grant for childhood leukemia research
$250,000 grant to support Dr. Cecilia Yeung’s work on pediatric acute leukemia
Fred Hutch Statement Regarding the FDA Action on CTL019 Immunotherapy
Fred Hutch expert comments on FDA approval of new Novartis immunotherapy drug CTL019 — August 30, 2017
Forum at Fred Hutch focuses on the hottest developments in cancer immunotherapy
Immune-based treatments move from the fringes to the spotlight